The U.S. Preventive Medicine® National Advisory Board will be composed of the Chairman and up to twenty members representing medical specialties, healthcare administration, academic health care institutions, benefits consultants and Fortune 100 employers.  The Company is pleased to announce Dr. David Nash as the National Advisory Board Chairman.

RONALD LOEPPKE, MD, MPH

Ron Loeppke, M.D., MPH, serves as Co-Chairman of the company's National Advisory Board. The Board is focused on researching the role of primary, secondary and tertiary prevention (health promotion, early detection and early intervention) in improving health and productivity in the workplace, as well as in the home.
 
Dr. Ron Loeppke is the former Chief Strategic Officer and Executive Vice President of Matria Healthcare, Inc. In this role he led the firm's strategic initiatives across the company as well as provided counsel on medical, health and productivity issues to Matria clients. Prior to joining Matria, Dr. Loeppke was Chief Medical Officer, Chief Strategic Officer, and Executive Vice President for CorSolutions. Before CorSolutions, Ron was the Founder, President and CEO of the Health and Productivity Corporation of America (HPCA), headquartered in Brentwood, Tennessee.

Dr. Loeppke is Board Certified and residency trained in Preventive Medicine as well as fellowship trained in Occupational Medicine. He is a Fellow of both the American College of Occupational and Environmental Medicine (ACOEM) and the American College of Preventive Medicine, (ACPM). He is Co-Chairman of the ACOEM Section on Health and Productivity, which is actively involved in defining and establishing measurement criteria for research in health and productivity initiatives, as well as assimilating input from practice experts in the field, employers, corporate medical directors, employer coalitions, pharmaceutical companies, the provider community, and other key stakeholders on the frontlines of the health and productivity arena.

Dr. Loeppke has over 20 years of clinical and physician executive experience in the Occupational Health, Preventive Medicine, and Medical Management arenas. He has authored numerous articles and book chapters relating to health and productivity, occupational health, managed care, quality care improvement, adoption of evidence based medicine, employer health initiatives, consumer driven healthcare, preventive medicine, and innovative models for the business of healthcare.

As the recent lead author of "Health and Productivity as a Business Strategy" in the Journal of Occupational and Environmental Medicine (JOEM), July 2007 issue Dr. Loeppke and his fellow researchers demonstrated that the total cost of poor health far surpassed medical and pharmacy claims alone.  The multi-employer based study determined two major results: 1) Health-related productivity costs were more than four times greater than medical and pharmacy costs. 2) The full cost of poor health is driven by different health conditions than those driving medical and pharmacy costs alone. The study demonstrates that Integrated Population Health & Productivity Management should be built on a foundation of Integrated Population Health & Productivity Measurement.

Therefore, employers should reveal a blueprint for action for their integrated health and productivity enhancement strategies by measuring the full health and productivity costs related to the burdens of illness and health risk in their population.


David Nash, MD, MBA, FACP, Co-Chair

Chairman, U.S. Preventive Medicine® National Advisory Board.  David Nash is the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy and Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia. Jefferson is one of a handful of medical schools in the nation with an endowed professorship in health policy. Dr. Nash, a board certified internist, continues to direct the Office of Health Policy and Clinical Outcomes at Jefferson University Hospital, which he founded in 1990. In 1996, he was named the first Associate Dean for Health Policy at Jefferson Medical College.

Internationally recognized for his work in outcomes management, medical staff development and quality-of-care improvement, his publications have appeared in more than 60 articles in major journals and in a dozen edited books, including A Systems Approach to Disease Management by Jossey-Bass Publishers and Connecting with the New Healthcare Consumer by Aspen Publishers. In 1995, he was awarded the Latiolais ("Lay-shee-o-lay") Prize by the Academy of Managed Care Pharmacy for his leadership in disease management and pharmacoeconomics. He also received the Philadelphia Business Journal Healthcare Heroes Award in October 1997 and was named an honorary distinguished fellow of the American College of Physician Executives in 1998.

Repeatedly named by Faulkner & Gray as one of the most influential policy makers in academic medicine, his national activities include appointment to the JCAHO Advisory Committee on Performance Measurement, the Foundation for Accountability (FACCT) Board, and the Disease Management Advisory Council of the NCQA - three key national groups focusing on quality measurement and improvement. He continues as one of the principal faculty members for quality of care issues of the American College of Physician Executives in Tampa, Florida, and the developer of the ACPE Capstone Course on Quality. Dr. Nash is on the National Advisory Committee for the Robert Wood Johnson Foundation Partnerships in Quality Education program, bringing together managed care organizations and leading academic medical centers. Finally, he is a member of the Board of Trustees of Catholic Healthcare Partners in Cincinnati, one of the nation’s largest integrated delivery systems and chairs the board committee on quality.

Dr. Nash is a consultant to organizations in both the public and private sectors including the Technical Advisory Group of the Pennsylvania Health Care Cost Containment Council (a group he has chaired for the last three years), Medscape and numerous corporations within the pharmaceutical industry. He is on the board of directors and advisory board of six national firms involved in healthcare ‘e’ commerce. He is on the editorial board of six peer-reviewed journals. From 1984 to 1989, he was Deputy Editor, Annals of Internal Medicine, at the American College of Physicians. Currently, he is Editor-in-Chief of both P&T and Disease Management. He is a member of the Medical Economics editorial board.

Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College, Poughkeepsie, New York; his MD from the University of Rochester School of Medicine and Dentistry; and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania. While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine physician faculty group practice in general internal medicine.

Dr. Nash and The Institute for Health Policy, in conjunction with the National Advisory Board, will:
  • Outline evidence-based practices, clinical research and scientific agenda.
  • Identify key strategic partners spanning academic, pharmaceutical, device, clinical, institutional, governmental, employer and insurance.
  • Establish an outcomes research agenda incorporating broad clinical publication.
  • Develop a communications strategy across medical, healthcare, employer, insurer, consumer and employer media.

NATIONAL ADVISORY BOARD MEMBERS

The National Advisory board will bring expertise to the Company’s leadership while providing important feedback across academic, research, medical, hospital, employer, insurer, benefits and disease management sectors.  The following members have accepted positions on the U.S. Preventive Medicine® National Advisory Board:

  1. SEAN SULLIVAN
      PRESIDENT/CEO
      INSTITUTE FOR HEALTH & PRODUCTIVITY MANAGEMENT
      GAINEY RANCH CENTER
      SCOTTSDALE, AZ

  2. F. KENNETH ACKERMAN, JR.
      PRESIDENT
      CLARK CONSULTING HEALTHCARE GROUP
      MINNEAPOLIS, MN

  3. ANN SCOTT BLOUIN, PHD, RN
      PRINCIPAL
      DELOITTE CONSULTING LLP
      CHICAGO, IL

  4. MAULIK JOSHI, DRPH

  5. ANTHONY DIMARINO, MD
      DIVISION CHIEF
      THOMAS JEFFERSON UNIVERSITY HOSPITAL
      GASTROENTEROLOGY & HEPATOLOGY
      PHILADELPHIA, PA

  6. MATIAS KLEIN
      PRESIDENT, CTO
      ETHIDIUM HEALTH SYSTEMS
      HUNTINGTON VALLEY, PA

  7. DAVID AUERBACH, MD MBA
      UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL
      DALLAS, TX

  8. JAMES FRIES, MD
      PROFESSOR OF MEDICINE, EMERITUS
      STANFORD UNIVERSITY
      STANFORD, CA

  9. JOHN FERRY, MD
      SENIOR VICE PRESIDENT
      NAVIGANT CONSULTING/THE HUNTER GROUP
      PROVIDENCE, RI

10. DICK TEWKSBURY
      TRION GROUP
      KING OF PRUSSIA, PA

11. BARRY BERCU, MD
      PROFESSOR OF PEDIATRICS
      PROFESSOR OF BIOCHEMISTRY & MOLECULAR BIOLOGY
      PROFESSOR OF PHARMACOLOGY & THERAPEUTICS
      UNIVERSITY OF SOUTH FLORIDA
      ALL CHILDRENS HOSPITAL
      ST. PETERSBURG, FL

12. ROBERT BUTLER, MD
      PRESIDENT & CEO
      INTERNATIONAL LONGEVITY CENTER - USA
      60 E 86TH STREET
      NEW YORK, NY

13. JASON PRIDE, CFA
      VICE PRESIDENT, DIRECTOR OF RESEARCH
      THE HAVERFORD TRUST COMPANY
      THREE RADNOR CORPORATE CENTER, SUITE 450
      RADNOR, PA